Press releases 4 Nov 2025 European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi
Press Releases Translations 4 Nov 2025 La Commission européenne investit 20 millions d’euros pour développer des médicaments contre la dengue en partenariat avec l’Agence française de développement et DNDi
In the media 21 Oct 2025 Vita dhidi ya ugonjwa wa Kala-azar vyazaa matunda Pokot baada ya mgonjwa kutibiwa na kupona TV47 Kenya
Viewpoints 9 Oct 2025 Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people STAT
News 3 Oct 2025 DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness
Viewpoints 30 Sep 2025 Le développement de médicaments pour les maladies négligées doit tenir compte des enfants Nature Africa
Scientific articles 30 Sep 2025 New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial BMJ Open
In the media 29 Sep 2025 Mobilisers on motorbikes: The complex process of involving communities in clinical trials Health Policy Watch
Scientific articles 29 Sep 2025 Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala Journal of the Brazilian Society of Tropical Medicine
Scientific articles 8 Aug 2024 The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis Trends in Parasitology
Scientific articles 5 Aug 2024 How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, highlighting the urgent need for a universal classification system in chronic Chagas disease PLOS Neglected Tropical Diseases
Scientific articles 1 Aug 2024 Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial Lancet Infectious Diseases
Scientific articles 15 Jul 2024 Differences in the cellular immune response during and after treatment of Sudanese patients with post-kala-azar dermal leishmaniasis, and possible implications for outcome Journal of Epidemiology and Global Health
Scientific articles 15 Jul 2024 Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements Wellcome Open Research
Scientific articles 2 Jul 2024 Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral leishmaniasis: A systematic review of published reports, 2000–2021 American Journal of Tropical Medicine and Hygiene
Scientific articles 20 Jun 2024 A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh PLOS Neglected Tropical Diseases
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Scientific articles 21 May 2024 Modular and divergent synthesis of 2,N3-disubstituted 4-quinazolinones facilitated by regioselective N-alkylation Organic and Biomolecular Chemistry
Scientific articles 20 May 2024 Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment Antimicrobial Agents and Chemotherapy
Scientific articles 16 May 2024 Chagas disease in the United States: a call for increased investment and collaborative research The Lancet Regional Health – Americas
Scientific articles 13 May 2024 Synthesis and anti-Trypanosoma cruzi activity of 3-cyanopyridine derivatives ACS Omega
Scientific articles 11 May 2024 In vivo bioluminescence imaging reveals differences in Leishmania infantum parasite killing kinetics by antileishmanial reference drugs ACS Infectious Diseases
Scientific articles 10 May 2024 Climate change, malaria and neglected tropical diseases: a scoping review Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 10 May 2024 Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia Journal of Antimicrobial Chemotherapy
Scientific articles 8 May 2024 Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns Helyon
